As readers of this blog are aware, Byetta (also called exenatide), the first approved medication in the class of diabetes drugs called "GLP-1 mimetics" or "GLP-1 receptor agonists", has been associated with a potentially fatal complication called pancreatitis. No one has been quite sure whether the pancreatitis complication is due to use of the drug, or coincidental -- as PWD have an increased incidence of pancreatitis. The FDA, however, has insisted on the manufacturer strengthening Byetta's...
